ACRIVON THERAPEUTICS INC

ACRV · NASDAQ

Updated at 2026-10-14 09:20:46

$1.75-7.89%
Today's High
$1.87
Today’s Low
$1.74
ACRIVON THERAPEUTICS INC (ACRV) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.91
Previous Close
$1.90
Volume
140.65K
Market Cap
$81.42M
P/E Ratio
--
EPS
$-1.88

Previous Day Range

$1.87$1.92

52-Week Range

$1.27$3.56

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
480 ARSENAL WAY, WATERTOWN, MA, UNITED STATES, 02472
Country
US
Listing Date
2022-11-15
Fiscal Year End
December
Shares Outstanding
42.8M
CIK
0001781174

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of precision cancer medicines. The company is headquartered in Watertown, Massachusetts.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$18.66M

2026-03-31

$19.51M

2025-12-31

$21.02M

2025-09-30

$19.68M

Net Income

2026-06-30

-$17.96M

2026-03-31

-$19.04M

2025-12-31

-$18.98M

2025-09-30

-$18.23M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.43

2026-03-31

$-0.49

2025-12-31

$-0.49

2025-09-30

$-0.47

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$17.55M

2026-03-31

-$18.65M

2025-12-31

-$24.83M

2025-09-30

-$17.88M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.